2'-O-Methyluridine-5'-Triphosphate - (N-1018)
Starting at $44.00
| Catalog No | N-1018 |
|---|---|
| Purity | ≥90% by AX-HPLC |
| Extinction Coefficient | 10,100 Lmol-1cm-1 at 262 nm |
| Molecular Formula | C10H17N2O15P3 (free acid) |
| Molecular Weight | 498.10 g/mole (free acid) |
| Salt Form | Li+ |
| Concentration | 100 mM |
| Buffer | H2O |
| Recommended Storage | -20°C or below |
| Other Name(s) | 2'-O-Methyl-UTP, 2'OMe-UTP |
| Application | Aptamers, Epigenetics/DNA Damage |
| Backbone | 5'-Triphosphate |
| Base Analog(s) | Uridine |
| Sugar Type(s) | 2'-O-Methyl |
| Nucleotide Category | Sugar Modified |
N-1018 Safety Data Sheet
Ask an Expert
CoA search tool
Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission of Seller. No license under any patent or other intellectual property right of Seller or its licensors is granted or implied by the purchase unless otherwise provided in writing.
TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser's sole responsibility.
-
-
-
-
-
2'-O-Methyl-2-aminoadenosine-5'-Triphosphate2'-O-Methyl-2-aminoadenosine-5'-Triphosphate
Starting at $99.00
-
-
2'-O-Methyl-5-methyluridine-5'-Triphosphate2'-O-Methyl-5-methyluridine-5'-Triphosphate
Starting at $70.00
-
N1-Methyl-2'-O-Methylpseudouridine-5'-TriphosphateN1-Methyl-2'-O-Methylpseudouridine-5'-Triphosphate
Starting at $99.00
- Karikó, Katalin; Muramatsu, Hiromi; Welsh, Frank A.; Ludwig, János; Kato, Hiroki; Akira, Shizuo; Weissman, Drew . Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
- Xiao, Zeyu; Levy-Nissenbaum, Etgar; Alexis, Frank; Lupták, Andrej; Teply, Benjamin A.; Chan, Juliana M.; Shi, Jinjun; Digga, Elise; Cheng, Judy; Langer, Robert; Farokhzad, Omid C. . Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection.
- Kanwar, Jagat R.; Roy, Kislay; Kanwar, Rupinder K. . Chimeric aptamers in cancer cell-targeted drug delivery.
- Lauridsen, Lasse H.; Rothnagel, Joseph A.; Veedu, Rakesh N. . Enzymatic recognition of 2'-modified ribonucleoside 5'-triphosphates: towards the evolution of versatile aptamers.
- Green, Nathaniel M.; Moody, Krishna-Sulayman; Debatis, Michelle; Marshak-Rothstein, Ann . Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.
- Lai, Zijuan; Tsugawa, Hiroshi; Wohlgemuth, Gert; Mehta, Sajjan; Mueller, Matthew; Zheng, Yuxuan; Ogiwara, Atsushi; Meissen, John; Showalter, Megan; Takeuchi, Kohei; Kind, Tobias; Beal, Peter; Arita, Masanori; Fiehn, Oliver . Identifying metabolites by integrating metabolome databases with mass spectrometry cheminformatics.
